Cancer :: Re-educating immune system cells slows tumour growth

Immune system cells recruited by cancers to help them grow and spread could be ‘re-educated’ to attack the tumours instead of aiding them, Cancer Research UK scientists announced at the National Cancer Research Institute (NCRI) Conference in Birmingham.

Eczema :: Specialized bath products for allergic eczema

Specialised bath products to relieve the symptoms of allergic (atopic) eczema are of “questionable” value, says the Drug and Therapeutics Bulletin (DTB). The NHS forks out more than £16 million a year on bath emollients, equivalent to almost 40% of the total cost of eczema treatments prescribed for pre-school children, says DTB.

Head and Neck Cancer :: Taxotere granted FDA approval to treat Head and Neck Cancer

Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere(R) (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.

Pregnancy :: Pregnancy after breast cancer is possible

U-M expert says new cancer treatments, technologies give women more hope of preserving fertility. Once Alyssa Tushman knew her young son would not grow up motherless, her next question was whether he would be an only child.

Influenza :: Tamiflu survives sewage treatment

Swedish researchers have discovered that oseltamivir (Tamiflu); an antiviral drug used to prevent and mitigate influenza infections is not removed or degraded during normal sewage treatment. Consequently, in countries where Tamiflu is used at a high frequency, there is a risk that its concentration in natural waters can reach levels where influenza viruses in nature will develop resistance to it.

Back Pain :: New clinical guideline for low back pain

A summary of evidence on the diagnosis and treatment of low-back pain has prompted the American Pain Society (ASP) and the American College of Physicians (ACP) to issue a new treatment guideline. The guideline is based on a thorough analysis of published research conducted by investigators at the Oregon Evidence-Based Practice Center at Oregon Health & Science University.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack